Inventory and Supply Chain Section: Key Insights for Manufacturing Company IPOs

The 2025 HKEX consultation on Chapter 9 of the Listing Rules, which proposed enhanced disclosure requirements for inventory valuation and supply chain dependencies in listing documents, signals a definitive shift in regulatory scrutiny for manufacturing IPO applicants. This follows the SFC’s 2024 enforcement action against a Main Board listed precision components manufacturer, where HK$428 million in inventory overstatements led to a suspension of trading and a subsequent investigation into the sponsor’s due diligence failures. For any manufacturing company eyeing a Hong Kong listing in 2025-2026, the inventory and supply chain section of the prospectus is no longer a back-office footnote; it is a primary risk factor that can determine sponsor liability, investor appetite, and the timeline to approval. The HKEX now expects applicants to provide granular, audited data on raw material price volatility, finished goods ageing profiles, and single-supplier concentration ratios, moving beyond standard boilerplate disclosures. This article dissects the specific structural requirements, common pitfalls, and strategic presentation choices that separate a robust IPO application from one that triggers multiple rounds of exchange queries.

The Regulatory Framework: What the HKEX and SFC Now Require

The HKEX’s Listing Decision HKEX-LD132-2024, issued in Q4 2024, explicitly clarified that inventory disclosures under Rule 9.16(3) must include a breakdown by category—raw materials, work-in-progress, and finished goods—with ageing schedules for each category exceeding 12 months. The SFC’s Code of Conduct for Persons Licensed by or Registered with the SFC (Chapter 17, paragraph 17.6) further mandates that sponsors must independently verify inventory quantities through physical counts and third-party confirmations, not merely rely on management representations. For manufacturing applicants with complex global supply chains, this means the prospectus must disclose the percentage of inventory held at third-party warehouses in jurisdictions such as the PRC, Vietnam, or Mexico, along with the legal recourse available if those goods are damaged or seized.

Primary Source Citation: HKEX Listing Decision HKEX-LD132-2024, “Disclosure of Inventory and Supply Chain Risks,” published November 2024.

H3: Inventory Valuation Methods and Their Impact on Profitability

The choice between weighted average cost (WAC) and first-in-first-out (FIFO) for inventory valuation directly affects reported gross margins and net profit, a point the HKEX scrutinises in its review of profit forecasts. A 2024 study by the Hong Kong Institute of Certified Public Accountants (HKICPA) found that manufacturing companies using FIFO during periods of rising raw material costs reported gross margins 3.2 to 4.7 percentage points higher than those using WAC, a discrepancy that can mislead investors if not clearly footnoted. The prospectus must disclose the valuation method for each inventory category and provide a sensitivity analysis showing the impact on net profit if the method were changed—a requirement under HKAS 2 Inventories, paragraph 36. For an applicant with HK$1.2 billion in raw material inventory, a shift from WAC to FIFO could inflate pre-tax profit by HK$48 million to HK$56 million, a materiality threshold that the HKEX will flag.

H3: Supply Chain Concentration Risk Disclosure

The SFC’s thematic review of IPO prospectuses in 2023 identified single-supplier concentration as the most common deficiency in the risk factors section. For a manufacturing applicant, if the top three suppliers account for more than 60% of total procurement spend, the prospectus must disclose the specific suppliers, their geographic locations, and the contractual terms governing supply continuity. The HKEX’s Guidance Letter GL94-18 (updated 2024) requires a table showing the percentage of purchases from each major supplier over the track record period, with a narrative explanation of any supplier that provides over 30% of a critical raw material. For example, a lithium battery manufacturer sourcing 72% of its cobalt from a single mine in the Democratic Republic of Congo must disclose the mine’s ownership structure, the political risk insurance in place, and the lead time to switch to an alternative supplier—typically 18 to 24 months for qualified alternatives.

Structuring the Inventory Section for Maximum Investor Confidence

The inventory section should be positioned immediately after the “Business Overview” chapter, not buried in the financial notes, as it provides the operational context for revenue recognition and working capital cycles. A well-structured section follows a three-part hierarchy: (1) inventory composition by category with ageing analysis, (2) inventory turnover ratios benchmarked against industry peers, and (3) supply chain dependencies and mitigation strategies. The HKEX’s Guide to Drafting Prospectuses (2024 edition) recommends that the narrative flow from quantitative data to qualitative risk assessment, rather than the reverse.

H3: Ageing Analysis and Provisioning for Obsolete Stock

The prospectus must present an ageing schedule for finished goods inventory, broken into 0-6 months, 6-12 months, 12-24 months, and over 24 months. For a manufacturing company with a product lifecycle of 18 months—common in consumer electronics components—any finished goods held for more than 12 months should be fully provisioned. The HKEX expects the provision for obsolete stock to be calculated using a specific methodology, disclosed in the accounting policies note. A 2025 analysis of 40 Main Board manufacturing IPOs found that companies with an average inventory holding period exceeding 90 days faced an average of 2.8 additional rounds of HKEX queries compared to those with holding periods under 60 days. The provision rate should be compared to actual write-offs in the track record period: if the provision rate is 5% but actual write-offs averaged 8.2% over three years, the sponsor must explain the discrepancy and justify the adequacy of the provision.

H3: Working Capital Cycle and Cash Conversion Days

The inventory section must tie directly to the working capital cycle disclosed in the “Financial Information” chapter. The cash conversion cycle (CCC) for a manufacturing company is calculated as days inventory outstanding (DIO) plus days sales outstanding (DSO) minus days payable outstanding (DPO). The HKEX requires a reconciliation of the CCC over the track record period, with explanations for any year-on-year change exceeding 15 days. For a precision machinery manufacturer with a DIO of 85 days, a DSO of 60 days, and a DPO of 45 days, the CCC is 100 days. If the industry average for comparable Main Board listed companies is 75 days, the prospectus must explain the deviation—whether due to longer production cycles, customer payment terms, or deliberate inventory build-up ahead of anticipated demand. The sponsor should include a sensitivity table showing the impact on free cash flow if the DIO is reduced by 10 days: for a company with annual revenue of HK$2.5 billion, a 10-day reduction in DIO would release approximately HK$68.5 million in cash.

Cross-Border Supply Chain Risks: Jurisdictional and Legal Considerations

For manufacturing companies with supply chains spanning multiple jurisdictions, the prospectus must address legal risks specific to each jurisdiction. The HKEX’s Listing Rules Chapter 19A (PRC issuers) and Chapter 19C (overseas issuers) require disclosure of any material legal or regulatory changes in the jurisdictions where suppliers are located that could disrupt supply. For a company sourcing from the PRC, the prospectus must discuss the impact of the PRC’s 2024 Foreign Trade Law amendments, which introduced new export control categories for dual-use goods. For a supplier in Vietnam, the prospectus should reference the Law on Foreign Trade Management (Law No. 05/2017/QH14) and its provisions on temporary import-export permits.

H3: Political Risk and Force Majeure Clauses

The prospectus must disclose the force majeure clauses in key supplier contracts and the legal recourse available if a supplier fails to deliver due to political instability, trade sanctions, or natural disasters. A 2024 survey by the Fung Business Intelligence Centre found that 67% of manufacturing companies in the Pearl River Delta had no force majeure clause covering trade war tariffs in their supplier contracts, a gap that the HKEX will expect to be addressed in the risk factors. The sponsor should include a legal opinion from a qualified law firm in the supplier’s jurisdiction, confirming the enforceability of the contract and the applicable dispute resolution mechanism—whether arbitration under the Hong Kong International Arbitration Centre (HKIAC) or litigation in the supplier’s local courts.

H3: Intellectual Property Protection in Supply Chains

For manufacturing companies that share proprietary designs or trade secrets with contract manufacturers, the prospectus must disclose the IP protection measures in place. The SFC’s Guidelines on Disclosure of Intellectual Property (2023) require the prospectus to list all patents, trademarks, and trade secrets relevant to the manufacturing process, and to confirm that confidentiality agreements with suppliers cover the entire supply chain, including sub-contractors. For a company manufacturing in the PRC under a VIE structure, the prospectus must address the enforceability of IP rights under PRC law, specifically the Patent Law (as amended in 2020) and the Anti-Unfair Competition Law (2019 revision). A failure to disclose a pending IP dispute with a former supplier—even if the dispute is in early-stage mediation—can result in the SFC issuing a suspension order under section 9 of the Securities and Futures Ordinance (Cap. 571).

Data Presentation: Tables, Charts, and Benchmarking

The HKEX’s Guidance on Prospectus Presentation (2024) encourages the use of tables and charts for inventory data, provided they are accompanied by narrative explanations. A table showing inventory composition by category and ageing should be followed by a chart comparing the applicant’s inventory turnover ratio to the median of five comparable Main Board listed companies. The comparable companies must be named, with their market capitalisations and business descriptions disclosed in a footnote. For a medical device manufacturer, the comparable set might include MicroPort Scientific Corporation (stock code: 0853) and Luye Medical Group (stock code: 0606), with their DIO figures sourced from their most recent annual reports.

H3: Key Financial Metrics Table

Metric	Applicant (FY2024)	Industry Median	Variance	Explanation
DIO (days)	92	78	+14	Higher due to customised production runs
Finished goods >12 months (%)	8.2%	4.5%	+3.7pp	Provisioned at 100% per accounting policy
Top 3 suppliers (% of purchases)	68%	45%	+23pp	Single-source for specialised raw material
Inventory turnover ratio (x)	3.9	5.2	-1.3	Reflective of longer production cycle

The table must be sourced from the applicant’s audited financial statements and the comparable companies’ annual reports, with the specific page references provided in the prospectus footnotes.

H3: Sensitivity Analysis for Raw Material Price Volatility

For manufacturing companies exposed to commodity price fluctuations—such as copper, steel, or lithium—the prospectus must include a sensitivity analysis showing the impact of a 10% and 20% change in raw material prices on gross profit and net profit. The analysis should be based on the applicant’s actual procurement volumes and hedge positions, not hypothetical scenarios. If the applicant has entered into forward contracts or swaps to hedge price risk, the prospectus must disclose the notional amount, the counterparty credit rating, and the mark-to-market valuation as of the latest practicable date. The HKEX’s Listing Rules Chapter 11, paragraph 11.10, requires that any derivative instruments used for hedging be disclosed in the financial statements, with a reconciliation to the inventory cost.

Closing Section: Actionable Takeaways for IPO Project Teams

1. Commission an independent inventory audit from a Big Four firm covering all material locations, including third-party warehouses, at least 12 months before the expected listing date, to identify and remediate any provisioning gaps.
2. Prepare a supply chain concentration table showing the top five suppliers by procurement value, their geographic locations, and the legal framework governing each contract, with a legal opinion from a local law firm for any supplier in a high-risk jurisdiction.
3. Ensure the inventory section includes a sensitivity analysis for raw material price volatility and foreign exchange exposure, using the same assumptions as the profit forecast, with explicit cross-references to the risk factors chapter.
4. Benchmark the applicant’s DIO, DSO, and DPO against a minimum of five comparable Main Board listed companies, sourced from their most recent annual reports, with the selection criteria disclosed in the prospectus.
5. Include a force majeure clause analysis for all contracts with suppliers accounting for more than 20% of total purchases, with a legal opinion confirming enforceability under the applicable law.